OpenVSafe by OpenVAERS
Search V-safe

3Q4-32631-62771

2 vaccinations 1 coded response 1 check-in 1 free-text entry 1 call case
Sex
Female
Age at first dose
36-40
ZIP prefix
207 / MD
Registered
2021-06-13
Relationship
Self
Race
Black or African American
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-04-11
    Dose 1 — Pfizer-BioNTech
  2. 2021-05-02
    Dose 2 — Pfizer-BioNTech
  3. 2021-06-13
    Registered in v-safe
  4. 2021-06-13
    Survey response — day 42, dose 2
    MedDRA: Emergency care, Fatigue, Syncope — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit
    Free text: After receiving my second dose, I've been experiencing extremely tiredness and fatigue. I had several episodes of syncope.I was taken to the emergency department twice with no resolution.I visited my primary care doctor but my symptoms persisted
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  5. 2021-06-13
    Report sent to call center — day 42, dose 2
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    1 call case(s)
  6. 2021-06-15
    Call successful
    Participant prefers to complete VAERS report online

Vaccinations

DoseDateManufacturerCo-administered
12021-04-11Pfizer-BioNTech
22021-05-02Pfizer-BioNTech

Call center

ReportedOutcomeVAERS-related outcome
2021-06-13 Successful
2021-06-15
Participant prefers to complete VAERS report online

Free text

Release 9 — day 42, dose 2

2021-06-13

Symptoms: After receiving my second dose, I've been experiencing extremely tiredness and fatigue. I had several episodes of syncope.I was taken to the emergency department twice with no resolution.I visited my primary care doctor but my symptoms persisted

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDEmergency care ✓ ✓ ✓
SDFatigue ✓ ✓ ✓
SDSyncope ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release